ACORN IQ
Technology/Service ProviderAt ACORN IQ, we are proud to be at the forefront of driving positive change in the healthcare industry. Through our patient recruitment services, we connect researchers with…

Almac provides the most comprehensive global clinical supply chain solution in the marketplace. Guided by our extensive supply experience, we provide the physical resources and supportive technologies that ensure your clinical supply chain continually delivers across the globe. Clinical trial supply chains are becoming longer and more complex, while costs are rising and sponsors face additional challenges to reduce waste, cost and timelines. As trials become truly global, sponsors require partners that can provide the physical means of packaging and distributing their supplies, as well as providing the data to facilitate planning and enable decision-making. We call this the physical and digital clinical supply chain. Our core services of clinical blinding, primary and secondary packaging and clinical distribution are designed with flexibility to fit your study requirement. Additionally, we are the only company in the market with supply chain planning, execution and IRT services under one roof – the most complete service available. This holistic view enables us to control all components of the supply chain and gives us the advantage to respond to ever-changing trial demands. It’s what keeps our customers coming back, time and time again.
At ACORN IQ, we are proud to be at the forefront of driving positive change in the healthcare industry. Through our patient recruitment services, we connect researchers with…
ResearchSmart is the leading collaborative platform for doing meaningful research. Seamlessly develop protocols, warehouse data and conduct analysis in a single platform. We offer…
Almac Clinical Technologies empowers the biopharmaceutical industry with a comprehensive suite of interoperable eClinical solutions. Our unified modular platform, Almac Trial…
Aparito’s mission is to digitise clinical trials and accelerate drug development for patients living with life-limiting diseases by supporting patient-centric clinical trials for…